Patents Assigned to MERZ PHARMACEUTICALS GMBH
  • Highly pure neurotoxic component of a botulinum toxin and uses thereof
    Patent number: 10653754
    Abstract: The present invention relates to a process for preparing a highly pure neurotoxic component of a botulinum toxin by cultivating Clostridium botulinum under conditions that allow production of a botulinum toxin, and isolating the neurotoxic component from the botulinum toxin. In addition, the present invention relates to a highly pure neurotoxic component of a botulinum toxin obtainable by the process of the present invention and uses thereof.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: May 19, 2020
    Assignee: Merz Pharmaceuticals GmbH
    Inventors: Michael Pfeil, Andreas Wiesenburg
  • Medicinal targeted local lipolysis
    Publication number: 20090275545
    Abstract: Aqueous phospholipid systems comprising at least one phospholipid, at least one bile acid and water are suitable for producing medicaments for the treatment of adipose tissue disorders and lead to regression of the pathologically proliferated adipose tissue.
    Type: Application
    Filed: July 10, 2009
    Publication date: November 5, 2009
    Applicant: MERZ PHARMACEUTICALS GMBH
    Inventors: Peter Boderke, Rainer Pooth, Juergen Sandow, Matthias Gossel, Karl-Heinz Nietsch, Gerhard Sattler, Gerhard Vogel